Background Amyloid transthyretin (ATTR) amyloidosis is a rare, life-threatening disease frequently manifesting with ...

Almost four years after penning its first amyloidosis collaboration with Neurimmune, AstraZeneca has returned to pick up a second asset. The latest licensing deal involves NI009, a preclinical ...

Transthyretin amyloid cardiomyopathy (ATTR-CM) is a condition that makes the heart stiff and less flexible, making it harder for the heart to pump. ATTR-CM doesn't always cause symptoms. When it does, ...

Living with transthyretin cardiac amyloidosis (ATTR-CM) can make everyday movement difficult. When you have this rare heart condition, blood protein deposits form amyloid fibrils that cause the heart ...

LOUISVILLE, KY, UNITED STATES, October 7, 2025 /EINPresswire.com/ -- 3DR Labs, the nation’s largest and most trusted provider of 3D medical image post-processing ...

Please provide your email address to receive an email when new articles are posted on . Acoramidis reduced cumulative CV outcomes vs. placebo in patients with cardiac amyloidosis. The curves separated ...

Over time, transthyretin amyloidosis (ATTR) can damage the nerves, heart, and other organs. This may lead to complications like heart problems, nerve damage, and trouble with everyday bodily functions ...

The life expectancy for transthyretin (ATTR) amyloidosis varies from person to person. Your age, overall health, and primary symptoms all play a role. Transthyretin amyloidosis (ATTR) is a rare ...

Transthyretin cardiac amyloidosis (ATTR-CA) is a frequent cause of heart failure (HF) in older Black individuals, particularly in the oldest men, the prospective SCAN-MP study affirms. The highest ...

Nuclear cardiologists are protesting the US Centers for Medicare & Medicaid Services potential 57% reimbursement cuts for pyrophosphate (PYP)/amyloid imaging, mere days before the comment period on ...